Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    Comparison of the effectiveness and safety of cefpodoxime and ciprofloxacin in acute exacerbation of chronic suppurative otitis media: A randomized, open-labeled, phase IV clinical trial

    Arijit Ghosh1, Utpal Jana2, Ajoy Khaowas2, Saumik Das2, Ananya Mandal1, Nina Das1 Corresponding author

    1. 1Department of Pharmacology, College, Kolkata, India Research Paper.
    2. 2Department of E.N.T., Nilratan Sircar Medical College, Kolkata, India Research Paper.

    CORRESPONDENCE

    Arijit Ghosh

    Department of Pharmacology, College, Kolkata, India Research Paper.

    Volume 3, Issue 4 · pp. 320–324 · PUBLISHED 2012 · DOI: 10.4103/0976-500X.103689

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Objective: To compare the effectiveness and safety of cefpodoxime and ciprofloxacin for the treatment of mild to moderate cases of acute exacerbation of chronic suppurative otitis media (AECSOM). Materials and Methods: Adult patients diagnosed with AECSOM were screened and patients fulfilling the inclusion criteria were randomized to receive either cefpodoxime 200 mg twice daily or ciprofloxacin 500 mg twice daily orally for 7 days. The primary outcome of this randomized, open-labeled, phase IV clinical trial (Registration Number - CTRI/2011/10/002079) was clinical success rate at day 14 visit and the secondary outcome was incidence of adverse events (AEs). Forty-six patients were enrolled: 23 in the cefpodoxime group and 23 in the ciprofloxacin group. Results: The clinical success rates were 95.6% in the cefpodoxime group versus 90.9% in the ciprofloxacin group. These rates are comparable, but no statistically significant difference was observed between the groups. Few mild and self-limiting AEs were observed and the tolerability of both the drugs was also good. Conclusion: The results of this randomized, open-labeled phase IV clinical trial showed that a 7-day course of cefpodoxime is therapeutically comparable to ciprofloxacin in terms of both clinical effectiveness and safety for the treatment of patients with AECSOM.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Ghosh, A., Jana, U., Khaowas, A., Das, S., Mandal, A., & Das, N. (2012). Comparison of the effectiveness and safety of cefpodoxime and ciprofloxacin in acute exacerbation of chronic suppurative otitis media: A randomized, open-labeled, phase IV clinical trial. Journal of Pharmacology and Pharmacotherapeutics, 3(4), 320–324. https://doi.org/10.4103/0976-500X.103689